Globus Medical

Health Manufacturing & Industrial medical devices medtech

Globus Medical, Inc. is a medical device company focused on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company's products are classified into two categories: Innovative Fusion and Disruptive Technologies. The Innovative Fusion products are used in cervical, thoracolumbar, sacral, and interbody, corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions.

Revenue(FY, 2016)

$564 M

Market capitalization(2018-06-14)

$5.5 B

Type

Public

Eagleville, US

Founded

2003

Size (employees)

1,400 (est)

Website

globusmedical.com

Globus Medical was founded in 2003 and is headquartered in Eagleville, US

Report incorrect company information

Key People/Management at Globus Medical

David C. Paul

Executive Chairman

David M. Demski

CEO

Anthony L. Williams

President

Daniel T. Scavilla

Senior Vice President and CFO

Eric Ian Schwartz

Senior Vice President and General Counsel

A. Brett Murphy

Group President, Commercial Operations

Report incorrect company information

Globus Medical Office Locations

Globus Medical has an office in Eagleville

Eagleville, US (HQ)

2560 General Armistead Ave

Show all (1)

Report incorrect company information

Globus Medical Financials and Metrics

Globus Medical Financials

Globus Medical's revenue was reported to be $563.99 m in FY, 2016 which is a 3.5% increase from the previous period.

Summary

USD
Revenue (Q1, 2018)	174.4 m
Gross profit (Q1, 2018)	136.4 m
Gross profit margin (Q1, 2018), %	78.2%
Net income (Q1, 2018)	39.5 m
EBIT (Q1, 2018)	45.6 m
Market capitalization (14-Jun-2018)	5.5 b
Closing share price (14-Jun-2018)	56.2
Cash (31-Mar-2018)	119.8 m

Globus Medical's current market capitalization is $5.5 b.

Income Statement

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Revenue	434.5 m	474.4 m	544.8 m	564 m
Revenue growth, %		9%	15%	4%
Cost of goods sold			132.8 m	134.7 m
Gross profit			412 m	429.3 m

Quarterly

USD	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017	Q1, 2018
Revenue	133.6 m	137 m	139.3 m	137.5 m	135.7 m	155.8 m	152.4 m	151.7 m	174.4 m
Cost of goods sold	32.6 m	33.1 m	31.6 m	32.9 m	31.5 m	35.6 m	37.2 m	36.8 m	38 m
Gross profit	101 m	103.9 m	107.6 m	104.6 m	104.2 m	120.2 m	115.2 m	114.9 m	136.4 m
Gross profit Margin, %	76%	76%	77%	76%	77%	77%	76%	76%	78%

show all

Balance Sheet

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Cash	90 m	82.3 m	60.2 m	132.6 m
Inventories	70.4 m	90.9 m	105.3 m	112.7 m
Current Assets	416.8 m	470 m	544.8 m	513.8 m

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017	Q1, 2018
Cash	101.9 m	104.6 m	136.5 m	169.4 m	75 m	41.6 m	50.5 m	81.3 m	95.3 m	90.2 m	182.4 m	149.7 m	154.9 m	119.8 m
Inventories	71.2 m	72.5 m	76.4 m	77.4 m	98.9 m	101 m	105.7 m	105.1 m	104.4 m	115.6 m	113 m	111.1 m	111.5 m	107.6 m
Current Assets	384.8 m	460.9 m	467.1 m	484.8 m	455.7 m	454.8 m	506.3 m	515.5 m	535.4 m	478.2 m	540.9 m	535.1 m	563.6 m	614.9 m
PP&E	63.6 m

show all

Cash Flow

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Net Income	68.6 m	92.5 m	112.8 m	104.3 m
Depreciation and Amortization	19.4 m	21.8 m	24.1 m	3.5 m
Inventories	(17 m)	(18 m)	(19 m)	(10.5 m)
Accounts Payable	1.8 m	4.6 m	(3.8 m)	(23 k)

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q3, 2017	Q1, 2018
Net Income	47.6 m	21.1 m	41.8 m	64.8 m	24.6 m	48.7 m	75.2 m	28 m	53.8 m	80 m	28.7 m	25.6 m	39.5 m
Depreciation and Amortization	14.2 m	5.3 m	10.7 m	16.1 m	5.7 m	11.6 m	17.7 m	6.7 m	13.7 m	21.5 m	1.8 m		9.5 m
Inventories	(15.7 m)	(4 m)	(9.5 m)	(12.5 m)	(7.4 m)	(11.7 m)	(17 m)	(2.3 m)	(3.8 m)	(6.6 m)	113 m	111.5 m	(1.2 m)
Accounts Payable	1 m	(1.1 m)	(821 k)	(2.3 m)	835 k	(66 k)	(2.8 m)	(1.2 m)	(1.7 m)	(3.4 m)	17 m	16.6 m	728 k